Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination

Heart Lung Circ. 2021 Dec;30(12):e119-e120. doi: 10.1016/j.hlc.2021.06.521. Epub 2021 Jul 15.

Authors

Martina Boscolo Berto¹, Giancarlo Spano¹, Benedikt Wagner², Benedikt Bernhard¹, Jonas Häner¹, Adrian T Huber², Christoph Gräni³

Affiliations

¹ Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Department of Diagnostic, Interventional and Paediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: christoph.graeni@insel.ch.

No abstract available

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
RNA, Messenger
SARS-CoV-2
Takotsubo Cardiomyopathy* / diagnosis
Takotsubo Cardiomyopathy* / etiology
Vaccination / adverse effects

Substances

COVID-19 Vaccines
RNA, Messenger